00078-1154 Tafinlar - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00078-1154

Brand Name:

Tafinlar

Generic Name:

Dabrafenib

Dosage Form Name:

TABLET, FOR SUSPENSION

Administration Route:

Oral

Substances:

Name: DABRAFENIB MESYLATE

Strength: 10.0

Unit: mg/1

Packages:

Code: 00078-1154-21

Description: 210 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-1154-21)

Effective Date: March 16, 2023

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

BRAF

Orphan Drug Designation:

Status:

In Use